Schizophrenia Trials

SND11

SND11 Adolescent Schizophrenia Study

The Adolescent Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among teenagers. Status: Actively Recruiting

SND12

SND12 Refractory Schizophrenia Study The Refractory Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among adults who did not respond to at least 2 current drug treatment and are currently receiving Clozapine. Status: Actively Recruiting

SND13

SND13 Adult Schizophrenia Study

The Adult Schizophrenia Study is a late (IIb/III) phase clinical study to examine the safety and efficacy of an investigational therapy named NaBen® in improving the symptoms of schizophrenia among adults between 18 and 45 years old.   Status: Actively Recruiting